Fisher Will Divest $17M Product Line to Satisfy FTC Request for Info Tied to Thermo Merger | GenomeWeb
NEW YORK (GenomeWeb News) – Fisher Scientific plans to divest an undisclosed product line after the Federal Trade Commission asked for information about that line as part of its review into Fisher’s planned merger with Thermo Electron, Fisher said yesterday.
 
Fisher said the product line is worth $17 million.
 
According to Fisher, the FTC had asked that it and Thermo Electron provide it with additional information about the line, which Fisher described as a “single, minor product line.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.